A Prospective, Non-Randomized, Evaluation of Low-Risk Patients Undergoing Carotid Stenting With ANgiomax (Bivalirudin)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01273350
Recruitment Status : Unknown
Verified July 2014 by Rajesh Dave, MD, SPSI d.b.a Capital Cardiovascular Associates.
Recruitment status was:  Recruiting
First Posted : January 10, 2011
Last Update Posted : July 31, 2014
Information provided by (Responsible Party):
Rajesh Dave, MD, SPSI d.b.a Capital Cardiovascular Associates

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : December 2016
  Estimated Study Completion Date : December 2017